Medication-Assisted Treatment (MAT) Treatment Centers
Medication-Assisted Treatment (MAT) combines FDA-approved medications with counseling and behavioral therapies to treat substance use disorders. For opioid addiction, medications like buprenorphine (Suboxone), methadone, and naltrexone (Vivitrol) reduce cravings and withdrawal symptoms, significantly improving treatment outcomes. For alcohol use disorder, medications like naltrexone, acamprosate, and disulfiram help maintain sobriety. Research shows MAT reduces overdose deaths, improves treatment retention, and increases the likelihood of long-term recovery. Despite stigma, MAT is considered the standard of care for opioid use disorder.
Found 0 treatment centers offering medication-assisted treatment (mat) across the United States.
Want us to find the perfect facility for you?
Call now - it's completely free!
Showing 0 of 0 medication-assisted treatment (mat) treatment centers
No Medication-Assisted Treatment (MAT) Treatment Centers Found
Try adjusting your search criteria or browse all treatment centers.
Browse All CentersAbout Medication-Assisted Treatment (MAT)
Medication-Assisted Treatment is the gold-standard, evidence-based approach for opioid use disorder, endorsed by the World Health Organization, SAMHSA, and the American Society of Addiction Medicine. According to NIDA, MAT reduces opioid overdose deaths by more than 50%. Despite this, only about 18% of the 2.5 million Americans with opioid use disorder receive MAT (SAMHSA 2023 National Survey on Drug Use and Health), representing a critical treatment gap.
Understanding MAT
Medication-Assisted Treatment combines FDA-approved medications with counseling and behavioral therapies. MAT is not "replacing one drug with another"—it is medical treatment for a chronic brain disorder that normalizes brain chemistry, reduces cravings, and allows individuals to focus on recovery.
FDA-Approved Medications for Opioid Addiction
- Buprenorphine (Suboxone, Subutex): A partial opioid agonist that reduces cravings and withdrawal. Can be prescribed by certified physicians in office settings.
- Methadone: A full opioid agonist dispensed through specialized clinics. Highly effective for severe addiction.
- Naltrexone (Vivitrol): An opioid blocker available as daily pills or monthly injection. Prevents opioid effects if someone uses.
FDA-Approved Medications for Alcohol Addiction
- Naltrexone: Reduces cravings and the pleasurable effects of alcohol
- Acamprosate (Campral): Helps maintain abstinence by reducing discomfort from not drinking
- Disulfiram (Antabuse): Creates unpleasant effects if alcohol is consumed
Why MAT Works
Research consistently shows MAT:
- Reduces overdose deaths by 50% or more
- Improves treatment retention significantly
- Reduces illicit drug use
- Decreases criminal activity
- Improves employment outcomes
- Reduces transmission of infectious diseases
Combining MAT with Therapy
MAT is most effective when combined with counseling and behavioral therapies. Treatment centers offering MAT typically also provide individual therapy, group counseling, CBT, and connections to support groups.
Addressing Stigma
Despite strong evidence, MAT faces stigma from some who view it as not "true recovery." Medical and addiction specialists, however, recognize MAT as essential healthcare. Just as diabetics take insulin, people with opioid addiction may need medication to maintain recovery.
What to Expect with MAT
MAT follows a structured medical protocol:
- Phase 1: Medical Assessment (Days 1–3) — Comprehensive evaluation including physical exam, substance use history, and medication selection. Medically managed detox may begin simultaneously
- Phase 2: Induction (Days 3–7) — Careful medication initiation under medical supervision. For buprenorphine, this requires a specific withdrawal state before starting. Methadone begins at low doses with gradual increases
- Phase 3: Stabilization (Weeks 2–8) — Dose optimization while beginning counseling and CBT or other behavioral therapies. Transition to intensive outpatient if appropriate
- Phase 4: Maintenance (Months 3+) — Ongoing medication management via standard outpatient, regular counseling, and recovery support. Duration varies — many experts recommend at least 12 months, some indefinitely
Treatment Outcomes & Research
A landmark study in The Lancet found MAT reduces all-cause mortality among people with opioid use disorder by 50%. The New England Journal of Medicine reported that buprenorphine doubles 12-month retention in treatment compared to placebo. The CDC confirms that expanding MAT access is the single most effective strategy for reducing opioid overdose deaths, which claimed over 80,000 lives in the U.S. in 2023.
Learn more about MAT:
Insurance & Payment for Medication-Assisted Treatment (MAT)
The Mental Health Parity and Addiction Equity Act (MHPAEA) and the Affordable Care Act (ACA) require most health insurance plans to cover substance use disorder and mental health treatment at the same level as medical and surgical care. This means medication-assisted treatment (mat) is typically covered when deemed medically necessary.
Coverage varies by plan and provider. Many treatment centers accept private insurance, Medicaid, Medicare, TRICARE, and offer sliding-scale fees. Contact your insurance company or the treatment center directly to verify benefits.
Helpful resources:
- Learn about insurance coverage for rehab
- Explore standard outpatient programs (often most affordable)
- Consider telehealth services for accessible, lower-cost options
- SAMHSA National Helpline — free, confidential, 24/7 referrals (1-800-662-4357)
- Medicaid.gov — check eligibility for state Medicaid coverage
Related Conditions & Treatments
Related Conditions
Other Treatment Methods
Levels of Care
Medical Disclaimer
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before making decisions about addiction treatment. If you or someone you know is in crisis, contact the 988 Suicide & Crisis Lifeline (call or text 988) or the SAMHSA National Helpline (1-800-662-4357).